Home

Sriram Venkataraman

CIK 1550642 · last filed 2023-01-30

Sriram Venkataraman is a corporate insider who has filed 14 SEC Form 4 insider transactions across 4 companies since 2016. Across all open-market trades the lifetime net is −$112.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $718.9M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$718.93M

Companies

4

Total Filings

14

Lifetime Open-Market Net

-$112.04M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
RVL Pharmaceuticals plc (RVLP) Delisted Director 23,730,864 $0.03 $669.2K $12.40M 2 2023-01-30
RVL Pharmaceuticals plc (OSMT) Delisted Director 1,032,995 $1.11 $1.15M $6.25M 2 2020-11-23
OptiNose, Inc. (OPTN) Delisted Director 675,758 $9.60 $6.49M -$71.59M 6 2020-06-12
LNTH Director 7,004,395 $102.64 $718.93M -$59.10M 2 2017-03-21

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-08-30 — Notice (144) −160,078 -$16.0K EDGAR
2023-08-24 — Notice (144) −140,767 -$19.7K EDGAR
2023-01-30 RVL Pharmaceuticals plc (RVLP) Delisted Other (J) −1,032,995 $0 EDGAR
2022-08-09 RVL Pharmaceuticals plc (RVLP) Delisted Buy (P) +8,000,000 $12.40M EDGAR
2020-11-23 RVL Pharmaceuticals plc (OSMT) Delisted Other (J) −4,936,926 $0 EDGAR
2020-06-12 OptiNose, Inc. (OPTN) Delisted Grant (A) — $0 EDGAR
2020-01-15 RVL Pharmaceuticals plc (OSMT) Delisted Buy (P) +1,250,000 $6.25M EDGAR
2019-11-26 OptiNose, Inc. (OPTN) Delisted Sell (S) −1,250,000 -$11.46M EDGAR
2019-06-10 OptiNose, Inc. (OPTN) Delisted Grant (A) — $0 EDGAR
2018-06-13 OptiNose, Inc. (OPTN) Delisted Sell (S) −2,875,000 -$60.13M EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.